Director Integrated Evidence Planning at Novartis shaping evidence generation strategies for global healthcare impact. Collaborating with cross-functional teams to support regulatory and market access success.
Responsibilities
Advise on the development of strategic, co-created Integrated Evidence Plans to support regulatory success, market success, and clinical adoption.
Guide squads in identifying evidence gaps and prioritizing high-impact opportunities across functions
Promote patient-centered, above-brand evidence strategies to reduce silos and drive innovation
Apply impact frameworks to assess business value and inform decision-making
Ensure global relevance by integrating input from priority countries like US, China, Germany, and Japan
Facilitate external validation of evidence gaps and proposed solutions
Drive continuous improvement of IEP processes through stakeholder feedback and optimization
Act as internal thought leader and change agent for Integrated Evidence Planning excellence
Collaborate cross-functionally to ideate evidence solutions that support labeling, access, and adoption
Champion a collaborative, entrepreneurial culture that embraces innovation and true integrated evidence generation.
Requirements
Advanced degree in life sciences or healthcare; MBA or equivalent preferred
Solid experience in pharma, academic research, or healthcare with focus on evidence generation
Proven leadership in cross-functional teams and managing change in complex global environments
Strong expertise in interventional, non-interventional trial design and real-world evidence methodologies
Benefits
Commitment to Diversity and Inclusion: Novartis is committed to building an outstanding, inclusive work environment and diverse teams' representative of the patients and communities we serve.
Learn more here: https://www.novartis.com/about/strategy/people-and-culture
Director of Reserving overseeing actuarial analysis within Workers Compensation Division at Berkshire Hathaway. Conducting key driver research and reporting findings to Senior Leadership.
Director of Reserving overseeing actuarial teams at the insurance company. Responsible for data analysis, team direction, and reporting to Senior Leadership.
Director of Reserving leading the reserving team in actuarial analysis and decision - making. Engaging with senior leadership and regulatory activities within the insurance industry.
Director in HEOR focusing on translating evidence into clear materials for U.S. dissemination. Collaborating with teams to support the development of impactful communication strategies.
Regional Director responsible for relationship management and business development in Northern California. Leading sales activities and consulting with financial advisors on investment strategies.
Senior Asset Quality Lead responsible for driving GCP quality and oversight for clinical assets at Pfizer. Ensuring quality risk management, inspection readiness, and regulatory compliance across asset teams.
Senior Director leading AI - driven biologics discovery at Amgen. Overseeing a multidisciplinary team to develop predictive modeling capabilities in biologics research.
Director of Government Contracts & Pricing managing compliance and pricing for US government programs at innovative medical device company Insulet. Overseeing government program administration and collaboration with senior leadership.
Manage operational elements and execution of clinical studies at IQVIA, ensuring delivery, time, quality, and customer satisfaction since pre - award to close - out.
Executive Director leading ACEC/MD's operations and advocacy for engineering firms in Maryland. Responsible for managing finances, strategic planning, and relationships with key stakeholders.